Both companies have forward P/Es well below the average of the S&P 500, which is still a sky-high level of 18.2. They also are in favor with analysts, as 2015 and 2016 earnings estimates have been moving higher giving them a Zacks Rank of #1 (Strong Buy).
Horizon is also a rare value AND growth company. Earnings are expected to rise 70% this year and another 39% next year.
But what else should investors take away from these two companies?
Horizon Pharma: http://www.zacks.com/stock/quote/HZNP?cid=CS-YOUTUBE-FT-VID
Dean Foods: http://www.zacks.com/stock/quote/DF?cid=CS-YOUTUBE-FT-VID
Follow us on StockTwits: http://stocktwits.com/ZacksResearch
Follow us on Twitter: https://twitter.com/ZacksResearch
Like us on Facebook: https://www.facebook.com/ZacksInvestmentResearch